Alzheimer's Disease Awareness

In this video interview, Thomas M. Wisniewski, MD, director of the Alzheimer's Disease Research Center and the Center for Cognitive Neurology at NYU Langone, discusses:

• how new targeting agents, approaches to modulate neuroinflammation and other interventions are making this “an exciting time in Alzheimer’s disease research”;
• whether positive data on medications targeting amyloid beta “will translate clear, clinical benefits” in ongoing trials;
• lifestyle modifications and medical interventions that can help reduce the risk for developing dementia and slow disease progression;
• the importance of supporting caregivers and providing them services; and
• making primary care physicians and geriatricians aware of how critical early diagnoses and interventions are.